Skip to content

A clinical study on the choice of intravenous general anesthetics and its adjuvant effect with electroconvulsive therapy on depression

Comparison of the effect of general anesthtics of s-ketamine and propofol in the treatment of depression with electroconvulsive therapy: a double-blinded RCT

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2200066566
Enrollment
Unknown
Registered
2022-12-09
Start date
2022-12-01
Completion date
Unknown
Last updated
2023-05-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Depression

Interventions

Propofol-ketamine group:Intravenous anesthesia with propofol and s-ketamine
S-ketamine group:Intravenous anesthesia with s-ketamine

Sponsors

The First Hospital of Shanxi Medical University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
12 Years to 100 Years

Inclusion criteria

Inclusion criteria: 1. Age= 12 years old; 2. Patients diagnosed with major depressive disorder using DSM-V or CCMD-3; 3. Patients and their families voluntarily participate and sign informed consent;

Exclusion criteria

Exclusion criteria: 1. Patients with serious physical diseases such as coronary heart disease, asthma, intracranial vascular malformations, and uncontrolled hypertension; 2. History of previous insufficiency of heart, liver, kidney and other organs; 3. There are foreign bodies such as pacemakers and intracranial electrodes in the body; 4. Those who are allergic to the anesthetic drugs of this study; 5. Those with a history of substance abuse; 6. People with other mental illnesses, such as schizophrenia, obsessive-compulsive disorder, anorexia nervosa, etc.; 7. Combined with other diseases that affect the assessment of cognitive function, such as cerebral infarction, brain retardation, trisomy 21, etc.; 8. History of ECT treatment in the past 3 months; 9. Women who are pregnant.

Design outcomes

Primary

MeasureTime frame
Depression Scale score;

Secondary

MeasureTime frame
Cognitive scale scores;Electroconvulsive therapy indicators;Electroconvulsive therapy anesthesia indicators;Incidence of adverse reactions;Serological indicators;

Countries

China

Contacts

Public ContactZhang Yanqing

The First Hospital of Shanxi Medical University

lillyblooming@163.com13935195692

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026